Ascendis Pharma A/S (ASND)

Ascendis Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 15, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,009	8,234	7,125	6,824	7,635	9,007
Market Cap Growth	33.63%	15.57%	4.41%	-10.63%	-15.23%	35.62%
Enterprise Value	12,284	8,416	7,347	6,449	6,676	7,922
Last Close Price	192.04	137.67	125.95	122.13	134.53	166.78
PS Ratio	19.81	21.87	24.17	124.77	863.17	1059.02
PB Ratio	-	-75.24	-44.24	24.25	7.60	8.78
P/TBV Ratio	-	-	-	24.70	7.64	8.84
EV/Sales Ratio	21.31	22.35	24.92	117.92	754.73	931.41
Debt / Equity Ratio	-4.22	-8.10	-4.42	1.93	0.12	0.11
Asset Turnover	0.53	0.36	0.28	0.05	0.01	0.01
Inventory Turnover	0.27	0.18	0.26	0.12	-	-
Quick Ratio	0.66	0.81	0.62	1.06	7.03	13.75
Current Ratio	1.02	1.17	0.95	1.29	8.03	14.02
Return on Equity (ROE)	-	-	-818.43%	-101.69%	-44.54%	-58.36%
Return on Assets (ROA)	-17.16%	-17.38%	-29.73%	-32.29%	-27.35%	-24.95%
Return on Capital (ROIC)	-33.13%	-27.89%	-44.83%	-39.89%	-29.42%	-26.42%
Earnings Yield	-2.67%	-4.75%	-7.47%	-9.13%	-5.71%	-5.69%
FCF Yield	-1.68%	-3.87%	-7.29%	-7.99%	-6.57%	-3.96%
Buyback Yield / Dilution	-4.73%	-2.85%	-0.38%	-2.37%	-8.21%	-8.84%

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q